A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

South Africa's Aspen Pharmacare has started registering GLP-1 drugs used to treat diabetes and obesity in markets where patents are expiring soon, for approval to start manufacturing and selling ...